Thank you Mozz for taking the time and effort to do this. PAR...

Thank you Mozz for taking the time and effort to do this.

PAR recently said they extended the agreement to cover additional clinical conditions, can they elaborate on this and how do they plan on approaching these opportunities given the current commitment to OA and MPS?

Have there been any interested parties in performing any research agreements for other clinical conditions? And if so what area / conditions where they interested in? (Probably commercial in confidence) particularly interested in if there was any research into Long Covid due to the success PAR has had with the twins.

Some anecdotal evidence that patients treated with iPPS have had significant weight loss (Liffort Hobley) any research gone into this?

not sure if my questions are appropriate, but as you know I do tend to ask some questions around this disease and that disease